Akebia Therapeutics | AKBA - 股本和储备



金融业
股票价格
USD
资产
USD 362.52M
现金及等价物
USD 162.64M
销售成本
USD 10.34M
流动资产
USD 243.48M
流动负债
USD 173.88M
债务
USD 46.51M
股息收益率
0
EBIT
USD -5.45M
EBITDA
USD 14.03M
员工
167
EPS每股收益
USD -0.04
股本和储备
USD 27.38M
销售毛利
USD 47.28M
债务利息支出
362.52M
贷款资金
USD 36.4M
市值
USD 218.8M
净收入
USD -12.24M
营业费用
USD 63.08M
营业利润
USD -5.45M
普通股股本
USD 265.43M
PE价格收益
1.63K
税前利润
USD -11.24M
销售收入
USD 57.62M
销售和管理费用
USD 23.53M
股票
USD 13M
贸易债权人
USD 8.39M
应收帐款人
USD 47.03M


股本和储备 更改 日
Acadia Pharmaceuticals USD 1.25B 20.68M 2026-03
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Akebia Therapeutics USD 27.38M 5.24M 2026-03
Alnylam Pharmaceuticals USD 1.08B 286.2M 2026-03
Amgen USD 9.19B 532M 2026-03
Ardelyx USD 148.62M 18.33M 2026-03
Astellas Pharma JPY 1.83T 65.92B 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
Bayer EUR 28.85B 2.9B 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Celltrion KRW 435.96B 16.26T 2025-12
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Exelixis USD 1.94B 225.57M 2026-03
Fresenius Medical Care EUR 14.2B 13.95B 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
Ironwood Pharmaceuticals USD -217.14M 44.69M 2026-03
J&J USD 81.19B 358M 2026-03
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Lexicon Pharmaceuticals USD 202.86M 95.32M 2026-03
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Moderna USD 7.41B 1.24B 2026-03
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organigram Holdings CAD 369.46M 20.33M 2025-12
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pharma Mar EUR 249.67M 2.16M 2026-03
Prothena USD 312.62M 32.14M 2026-03
PTC Therapeutics USD -180.46M 24.85M 2026-03
Qiagen NV USD 3.78B 128.73M 2025-12
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Sartorius EUR 2.73B 1.14B 2026-03
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Tectonic Therapeutic USD 230.42M 20.91M 2026-03
Tilray USD 1.58B 39.08M 2025-09
Vanda Pharmaceuticals USD 327.19M 138.81M 2025-12
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 15.21B 740.32M 2026-03